期刊文献+

老年脑血管病患者血浆溶血磷脂酸水平的变化及其临床意义

下载PDF
导出
摘要 目的探讨老年脑血管病患者血浆溶血磷脂酸(LPA)水平的变化。方法采用紫外比色法检测血浆LPA含量。结果TIA组、脑梗死组、脑出血组及对照组初查时血浆LPA浓度分别为3.96±1.44umol/L、2.75±1.05umol/L、1.87±0.82umol/L、1.82±0.81umol/L。TIA组、脑梗死组两组间LPA结果差异显著(P<0.01),且均高于脑出血组及对照组(P<0.01)脑出血组及对照组之间LPA浓度差异无显著性意义(P>0.05)。TIA组、脑梗死组经临床抗凝抗血小板治疗2周后,LPA浓度明显降低(P<0.001)。而脑出血组,复查时LPA浓度水平却无明显改变(P>0.05)。结论血浆中LPA为体内凝血和血栓形成过程中早期释放的分子标记物,其浓度测定可作为短暂性脑缺血、脑死诊断的重要指标。在预测脑血管病的发生,转归及指导合理应用抗血小板及抗凝药物方面有重要的临床应用价值。
作者 刘桂娟 周平
出处 《医学检验与临床》 2005年第6期47-,42,共2页 Medical Laboratory Science and Clinics
  • 相关文献

参考文献6

  • 1伍期专.溶血磷脂酸在心脑血管疾病诊断及病因学中的作用[J].中华老年心脑血管病杂志,2003,5(2):77-79. 被引量:66
  • 2孙玉衡,伍期专,姚存姗,黄世昌,唐朝枢,李振光,包鹤丘,李松,周伟仅.缺血性脑卒中患者血浆溶血磷脂酸水平的初步研究[J].中华医学杂志,2002,82(4):229-231. 被引量:106
  • 3Moolenaar W H.LysophOsphatidi cacid,a multifunctional phospholidmessenger. Journal of Biological Chemistry . 1995
  • 4Gueguen G,Gaige B,Grevy J M,et al.Structure-activity analysis of theeffects of lysophosphatidic acid on platelet aggregation. Biochemistry . 1999
  • 5Smyth SS,Hillery CA,Parise LV.Fibrinogen binding to purified plateletelycoprotein IIb-IIIa(integrin alpha IIb beta3)is modulated by lipids. Journal of Biological Chemistry . 1992
  • 6Gerrard JM,Robinson P,Narvey M,et al.Increased phosphatidic acid anddecreased lysophosphatidic acid in response to thrombin is associated withinhibitibD of platelet aggregation. Biochemistry and Cell Biology . 1993

二级参考文献12

  • 1Moolenaar WH. Lysophosphatidic acid,a multifunctional phospholipid messenger. J Biol Chem,1995, 270: 12949-12952.
  • 2Tokumura A, Iimori M, Nishioka Y, et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol,1994, 267: C204-210.
  • 3Jalink K, Hordijk PL, Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta,1994, 1198: 185-196.
  • 4Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JAMA, 1998,280: 719-723.
  • 5Eichholtz T,Jalink K,Fahrenfort I,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J,1993, 291 : 677-680.
  • 6Torti M, Tolnai Festetics E, Bertoni A, et al. Activation of human platelets by lysophosphatidic acid. Blood Coagul Fibrinolysis,1996,7: 253-255.
  • 7Zhang J, Rittenhouse SE. Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of wortmannin on phosphoinositide 3-kinase and aggregation. Biochem Biophys Res Commun,1995, 211: 484-490.
  • 8Gueguen G, Gaige B, Grevy JM,et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry,1999,38: 8440-8450.
  • 9Gerrard JM, Robinson P.Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta, 1989, 1001: 282-285
  • 10Gerrard JM,Robinson P,Narvey M,et al. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation,Biochem Cell Biol,1993, 71: 432-439.

共引文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部